Evidence map›Paper›PMID 38600571›Full record

ArticleAddiction science & clinical practice2024

Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use disorder.

Gavin Bart, P Todd Korthuis, Julie M Donohue, Hildi J Hagedorn, Dave H Gustafson, Angela R Bazzi, Eva Enns, Jennifer McNeely, Udi E Ghitza, Kara M Magane and 5 more

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in Addiction science & clinical practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04921787 (Exemplar Hospital Initiation Trial to Enhance Treatment Engagement - Implementation Trial of High Intensity Versus Low Intensity Strategy for Supporting Hospital-Based Opioid Use Disorder Treatment), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04921787 naactive not recruitingnot on this map

Exemplar Hospital Initiation Trial to Enhance Treatment Engagement - Implementation Trial of High Intensity Versus Low Intensity Strategy for Supporting Hospital-Based Opioid Use Disorder Treatment

TypeinterventionalSponsorGavin BartRan2021 to 2026Enrolled24ConditionsSubstance Use Disorders, Opioid Use Disorder, Severe, Opioid Use Disorder, ModerateArmsLow Intensity, High Intensity
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 1 country.

Gavin BartDepartment of Medicine, Hennepin Healthcare and University of Minnesota, 701 Park Avenue, Minneapolis, MN, 55415, USA. bartx005@umn.edu.
P Todd KorthuisDepartment of Medicine, Addiction Medicine Section, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, 97239-3098, Portland, OR, USA.
Julie M DonohueDepartment of Health Policy and Management, University of Pittsburgh School of Public Health, Pittsburgh, PA, 15261, USA.
Hildi J HagedornCenter for Care Delivery & Outcomes Research, Minneapolis VA Health Care System, University of Minnesota, 1 Veterans Drive, Minneapolis, MN, 55417, USA.
Dave H GustafsonCenter for Health Enhancement Systems Studies, University of Wisconsin, 1513 University Ave., Madison, WI, 53706, USA.
Angela R BazziHerbert Wertheim School of Public Health, University of California, San Diego; La Jolla, CA, USA.
Eva EnnsDivision of Health Policy and Management, University of Minnesota School of Public Health, 420 Delaware St. SE, Minneapolis, MN, 55408, USA.
Jennifer McNeelyDepartment of Population Health, Section on Alcohol, Tobacco and Drug Use, NYU School of Medicine, 180 Madison Avenue, 17th floor, New York, NY, 10016, USA.
Udi E GhitzaNational Institute on Drug Abuse (NIDA) Center for the Clinical Trials Network (CCTN), Bethesda, MD, 20892, USA.
Kara M MaganeBoston University School of Public Health, 801 Massachusetts Ave, Suite 431, Boston, MA, 02118, USA.
Paulette BaukolBerman Center for Outcomes & Clinical Research, 701 Park Ave, Ste. PP7.700, Minneapolis, MN, 55415, USA.
Ashley VenaThe Emmes Company, LLC, 401 N. Washington St. #700, Rockville, MD, 20850, USA.
Jacklyn HarrisThe Emmes Company, LLC, 401 N. Washington St. #700, Rockville, MD, 20850, USA.
Delia VoroncaThe Emmes Company, LLC, 401 N. Washington St. #700, Rockville, MD, 20850, USA.
Richard Saitz *Boston University School of Public Health, 801 Massachusetts Ave, Suite 431, Boston, MA, 02118, USA.
Boston University · USEmmes (United States) · USUniversity of Minnesota · USBerman Center for Outcomes and Clinical Research · USMinnesota Department of Health · USNational Institute on Drug Abuse · USNew York University · USOregon Health & Science University · USRegeneron (United States) · USUniversity of Pittsburgh · US

Funding

Suicide Prediction and Prevention for People at Risk for Opioid Use DisorderUG1DA040316 · NIDA · HENNEPIN HEALTHCARE RESEARCH INSTITUTE · PI GAVIN BART · 2015 to 2026
$42.2M
PROCESS DEVELOPMENT OF TELACEBEC FOR TUBERCULOSIS75N95024D00012 · NIDA · MIDWEST RESEARCH INSTITUTE · PI SLADE, DESMOND · 2024 to 2025
$742k
SCIENTIFIC, OPERATIONS, AND ADMINISTRATIVE RESOURCES (SOAR) TO NIH.75N95021D00012 · NIDA · KELLY SERVICES, INC. · PI SPROSE, SARA · 2021 to 2021
$57k
NIDA NIH HHS 75N95021D00012NIDA NIH HHS 75N95024D00012NIDA NIH HHS Contract No. 75N95020D00012NIDA NIH HHS UG1 DA040316NIDA NIH HHS UG1DA040316NIEHS NIH HHS 75N96020D00012ORFDO NIH HHS 75N99020D00012
6 · The paper itself

Abstract

backgroundHospitalizations involving opioid use disorder (OUD) are increasing. Medications for opioid use disorder (MOUD) reduce mortality and acute care utilization. Hospitalization is a reachable moment for initiating MOUD and arranging for ongoing MOUD engagement following hospital discharge. Despite existing quality metrics for MOUD initiation and engagement, few hospitals provide hospital based opioid treatment (HBOT). This protocol describes a cluster-randomized hybrid type-2 implementation study comparing low-intensity and high-intensity implementation support strategies to help community hospitals implement HBOT.

methodsFour state implementation hubs with expertise in initiating HBOT programs will provide implementation support to 24 community hospitals (6 hospitals/hub) interested in starting HBOT. Community hospitals will be randomized to 24-months of either a low-intensity intervention (distribution of an HBOT best-practice manual, a lecture series based on the manual, referral to publicly available resources, and on-demand technical assistance) or a high-intensity intervention (the low-intensity intervention plus funding for a hospital HBOT champion and regular practice facilitation sessions with an expert hub). The primary efficacy outcome, adapted from the National Committee on Quality Assurance, is the proportion of patients engaged in MOUD 34-days following hospital discharge. Secondary and exploratory outcomes include acute care utilization, non-fatal overdose, death, MOUD engagement at various time points, hospital length of stay, and discharges against medical advice. Primary, secondary, and exploratory outcomes will be derived from state Medicaid data. Implementation outcomes, barriers, and facilitators are assessed via longitudinal surveys, qualitative interviews, practice facilitation contact logs, and HBOT sustainability metrics. We hypothesize that the proportion of patients receiving care at hospitals randomized to the high-intensity arm will have greater MOUD engagement following hospital discharge. DISCUSSION: Initiation of MOUD during hospitalization improves MOUD engagement post hospitalization. Few studies, however, have tested different implementation strategies on HBOT uptake, outcome, and sustainability and only one to date has tested implementation of a specific type of HBOT (addiction consultation services). This cluster-randomized study comparing different intensities of HBOT implementation support will inform hospitals and policymakers in identifying effective strategies for promoting HBOT dissemination and adoption in community hospitals.

trial registrationNCT04921787.

Indexed as

BuprenorphineOpioid-Related DisordersAnalgesics, OpioidHospitalizationHospitalsHumansOpiate Substitution TreatmentPatientsRandomized Controlled Trials as TopicAnalgesics, OpioidBuprenorphineImplementationMedications for opioid use disorderOpioid use disorderPractice facilitationProtocol

Identifiers

PMID38600571
PMCPMC11007900
OpenAlexW4394724651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.